BioSymetrics vs Deep Genomics
BioSymetrics vs Deep Genomics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BioSymetrics is on 63/100 and Deep Genomics on 61/100.
Where each one leads
BioSymetrics
- agent readiness: 46/100 against 35/100
- headcount growth: +139.3% against +19.3%
Deep Genomics
- domain rating: 54/100 against 30/100
- headcount: 110 against 14
- funding raised: $241M against $6.6M
- LinkedIn following: 30,891 against 3,571
At a glance
| Measure | BioSymetrics | Deep Genomics |
|---|---|---|
| What it is | Phenomics-driven AI company translating disease biology into precision medicine discoveries. | AI-powered biotechnology company developing RNA therapeutics for genetic diseases. |
| Category | Biotech, HealthTech, Drug Discovery, Genomics | Biotech, Drug Discovery, Genomics, AI-Driven Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2017 | 2015 |
| Headquarters | Boston, United States | Toronto, Canada |
| Status | Active | Active |
Size, funding and growth
| Measure | BioSymetrics | Deep Genomics |
|---|---|---|
| Employees | 14 | 110 |
| Headcount growthLast 12 months | +139.3% | +19.3% |
| Total funding | $6.6M | $241M |
| Latest round | Seed | Series C |
| LinkedIn followers | 3,571 | 30,891 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BioSymetrics | Deep Genomics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 63/100 | 61/100 |
| Traction | Not published | 60/100 |
| Team | 96/100 | 60/100 |
| Search visibility | 64/100 | 33/100 |
| Quality | Not published | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (46/100) | F (35/100) |
| Domain ratingLink authority, 0-100 | 30/100 | 54/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BioSymetrics | Deep Genomics |
|---|---|---|
| Hosting | Not detected | Self Managed |
| Analytics | Not detected | Google Analytics 4, Segment |
| Open source | Yes | No |
BioSymetrics vs Deep Genomics: common questions
Which is better, BioSymetrics or Deep Genomics?
On our 0-100 score BioSymetrics rates higher (63/100 against 61/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do BioSymetrics and Deep Genomics compare on the numbers?
BioSymetrics leads on agent readiness (46/100 against 35/100), headcount growth (+139.3% against +19.3%). Deep Genomics leads on domain rating (54/100 against 30/100), headcount (110 against 14), funding raised ($241M against $6.6M), LinkedIn following (30,891 against 3,571).
Read the full BioSymetrics review and pricing or the Deep Genomics review and pricing. You can also browse other BioSymetrics alternatives we track.